AVDL - Avadel Pharmaceuticals EPS beats by $0.04 November, 09 2020 07:04 AM Avadel Pharmaceuticals plc Avadel Pharmaceuticals (AVDL): Q3 GAAP EPS of -$0.20 beats by $0.04.Cash, cash equivalents and marketable securities of $231.6MPress Release For further details see: Avadel Pharmaceuticals EPS beats by $0.04